Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mouillac

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Biochemistry|August 1, 1997
Efficient photoaffinity labeling of the rat V1a vasopressin receptor using a linear azidopeptidic antagonistE Carnazzi, A Aumelas, S Phalipou, et al.
The Journal of Biological Chemistry|October 29, 1998
Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptorN Cotte, M N Balestre, S Phalipou, et al.
FEBS Letters|January 19, 1999
The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activitiesD Morin, N Cotte, M N Balestre, et al.
The Journal of Biological Chemistry|October 23, 1997
Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonistS Phalipou, N Cotte, E Carnazzi, et al.
European Journal of Pharmacology|March 15, 1994
Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptorG Y Ng, B Mouillac, S R George, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Genomic and non-genomic mechanisms of oxytocin receptor regulationH H Zingg, E Grazzini, C Breton, et al.
Journal of Receptor and Signal Transduction Research|March 11, 1999
Functional architecture of vasopressin/oxytocin receptorsM Hibert, J Hoflack, S Trumpp-Kallmeyer, et al.
Journal of Neuroendocrinology|March 2, 2012
Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeuticsM Manning, A Misicka, A Olma, et al.
The Journal of Biological Chemistry|October 27, 1995
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regionsB Mouillac, B Chini, M N Balestre, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor familyB Chini, B Mouillac, Y Ala, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Biochemistry|August 1, 1997
Efficient photoaffinity labeling of the rat V1a vasopressin receptor using a linear azidopeptidic antagonistE Carnazzi, A Aumelas, S Phalipou, et al.
The Journal of Biological Chemistry|October 29, 1998
Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptorN Cotte, M N Balestre, S Phalipou, et al.
FEBS Letters|January 19, 1999
The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activitiesD Morin, N Cotte, M N Balestre, et al.
The Journal of Biological Chemistry|October 23, 1997
Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonistS Phalipou, N Cotte, E Carnazzi, et al.
European Journal of Pharmacology|March 15, 1994
Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptorG Y Ng, B Mouillac, S R George, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Genomic and non-genomic mechanisms of oxytocin receptor regulationH H Zingg, E Grazzini, C Breton, et al.
Journal of Receptor and Signal Transduction Research|March 11, 1999
Functional architecture of vasopressin/oxytocin receptorsM Hibert, J Hoflack, S Trumpp-Kallmeyer, et al.
Journal of Neuroendocrinology|March 2, 2012
Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeuticsM Manning, A Misicka, A Olma, et al.
The Journal of Biological Chemistry|October 27, 1995
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regionsB Mouillac, B Chini, M N Balestre, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor familyB Chini, B Mouillac, Y Ala, et al.
Pageof 4